This list is based on the watchlists of people on Stock Events who follow BVNXF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Show more...
FAQ
What is Bioventix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Bioventix stocks are traded under the ticker BVNXF.
When is the next Bioventix earnings date?▼
Bioventix is going to release the next earnings report on October 26, 2026.
What were Bioventix earnings last quarter?▼
BVNXF earnings for the last quarter are 0.92 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
Does Bioventix pay dividends?▼
Yes, BVNXF dividends are paid semi-annual. The last dividend per share was 0.94 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Bioventix located?▼
Bioventix operates in the Other sector.
When did Bioventix complete a stock split?▼
Bioventix has not had any recent stock splits.